4篇
您的检索式：作者名="David Hall C"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas显示文摘Pancreatic cancer is one of the deadliest cancers with a very poor prognosis. Recently, there has been a significant increase in research directed towards identifying potential biomarkers that can be used to diagnose and provide prognostic information for pancreatic cancer. These markers can be used clinically to optimize and personalize therapy for individual patients. In this review, we focused on 3 biomarkers involved in the DNA damage response pathway and the necroptosis pathway: Chromodomainhelicase-DNA binding protein 5, chromodomain-helicaseDNA binding protein 7, and mixed lineage kinase domain-like protein. The aim of this article is to review present literature provided for these biomarkers and current studies in which their effectiveness as prognostic biomarkers are analyzed in order to determine their future use as biomarkers in clinical medicine. Based on the data presented, these biomarkers warrant further investigation,and should be validated in future studies. | Crystal S Seldon Lauren E Colbert William A Hall Sarah B Fisher David S Yu Jerome C Landry | 2016 | World Journal of Gastrointestinal Oncology2016，8，4： | 2 |
| 2 | Chloroplast isolation from Laminaria digitata (Phaeophyceae): A reproducible methodology yielding photosynthetically active chloroplasts显示文摘 | Dragana Strbac Marcoaurelio A. Rodrigues César P. Santos David O. Hall | 1994 | Planta1994，，1： | 1 |
| 3 | Development of an automated high-performance liquid chromatographic method for the on-line pre-concentration and determination of trace concentrations of pesticides in drinking water显示文摘 | Chrish Marvin Ian D Brindle David Hall C | 1990 | Journal of chromatography1990，503，： | 1 |
| 4 | Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial显示文摘 | Paul Emery Ferdinand C Breedveld Stephen Hall Patrick Durez David J Chang Deborah Robertson Amitabh Singh Ronald D Pedersen Andrew S Koenig Bruce Freundlich | 2008 | The Lancet2008，，9636： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员